Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct;15(7):1447-53.
doi: 10.1007/s10461-011-9951-9.

Medication adherence: tailoring the analysis to the data

Parya Saberi  1 , Mallory O Johnson, Charles E McCulloch, Eric Vittinghoff, Torsten B Neilands
Affiliations

Medication adherence: tailoring the analysis to the data

Parya Saberi et al. AIDS Behav. 2011 Oct.

Abstract

The purpose of this paper is to explore more comprehensive methods to analyze antiretroviral non-adherence data. Using illustrative data and simulations, we investigated the value of using binary logistic regression (LR; dichotomized at 0% non-adherence) versus a hurdle model (combination of LR plus generalized linear model for >0% non-adherence) versus a zero-inflated negative binomial (ZINB) model (simultaneously modeling 0% non-adherence and >0% non-adherence). In simulation studies, the hurdle and ZINB models had similar power but both had higher power in comparison to LR alone. The hurdle model had higher power than ZINB in settings where covariate effects were restricted to one or the other part of the model (0% non-adherence or degree of non-adherence). Use of the hurdle and ZINB models are powerful and valuable approaches in analyzing adherence data which yield a more complete picture than LR alone. We recommend adoption of this methodology for future antiretroviral adherence research.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Probability of type I error with logistic, hurdle, and ZINB models in the Sample Size Scenario using samples sizes 200 to 3,000. Dark green color (formula image) corresponds to results using data generated under the hurdle model, orange color (formula image) represents results using data generated under the ZINB model. Long dashes (formula image) are results of the LR analysis, short dashes (formula image) are results of the hurdle model analysis with the bonferroni test, short dash dots (formula image) are results of the hurdle model analysis with the omnibus test, and solid lines (formula image) are results of the ZINB model analysis.
Figure 2
Figure 2
Comparison of power between logistic, hurdle, and ZINB models in the Sample Size Scenario using samples sizes 200 to 3,000. Dark green color (formula image) corresponds to results using data generated under the hurdle model, orange color (formula image) represents results using data generated under the ZINB model. Long dashes (formula image) are results of the LR analysis, short dashes (formula image) are results of the hurdle model analysis with the bonferroni test, short dash dots (formula image) are results of the hurdle model analysis with the omnibus test, and solid lines (formula image) are results of the ZINB model analysis.
See this image and copyright information in PMC

References

    1. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30. - PubMed
    1. Chesney MA, Ickovics J, Hecht FM, Sikipa G, Rabkin J. Adherence: a necessity for successful HIV combination therapy. AIDS. 1999;13(Suppl A):S271–8. - PubMed
    1. Blower SM, Aschenbach AN, Gershengorn HB, Kahn JO. Predicting the unpredictable: transmission of drug-resistant HIV. Nat Med. 2001;7(9):1016–20. - PubMed
    1. Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis. 2002;34(8):1115–21. - PubMed
    1. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134(10):968–77. - PubMed

Publication types

Substances